Effects of delta9-tetrahydrocannabinol and cannabinol in man
- PMID: 1221432
- DOI: 10.1159/000136944
Effects of delta9-tetrahydrocannabinol and cannabinol in man
Abstract
The interaction of delta9-tetrahydrocannabinol (delta9-THC) and cannabinol (CBN) was studied in man. Five male volunteers were given placebo, 50 mg CBN, 25 mg delta9-THC, 12.5 mg delta9-THC + 25 mg CBN, and 25 mg delta9-THC + 50 mg CBN (orally). Administrations were spaced 1 week apart. With physiological measures, delta9-THC produced an increase in heart rate while CBN did not. When combined, no change of the delta9-THC effect occurred. No changes occurred on the electrocardiogram, blood pressure, or body temperature. With psychophysical measures no changes occurred in pain thresholds or skin sensitivity as a function of drug treatment. In time estimates of the passage of 1 minute, delta9-THC alone produced underestimates of the passage of 1 minute and CBN alone had no effect. In combination the two drugs had a tendency to produce significant overestimates and underestimates of the passage of 1 minute. On a 66-item adjective-pair drug reaction scale, the volunteers reported feeling drugged, drunk, dizzy, and drowsy under the delta9-THC condition, but not under the CBN condition. With combined drug treatment, volunteers reported feeling more drugged, drunk, dizzy, and drowsy than under the delta9-THC condition alone. None of the drug treatments produced significant changes on other items which included items on perception, emotion, cognition and sociability. It appears that CBN increases the effect of delta9-THC on some aspects of physiological and psychological processes, but that these effects are small and cannot account for the greater potency which has been reported when plant material is used.
Similar articles
-
Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.Clin Pharmacol Ther. 1975 Jul;18(1):80-3. doi: 10.1002/cpt197518180. Clin Pharmacol Ther. 1975. PMID: 1097148 Clinical Trial.
-
Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.Psychopharmacologia. 1975;41(3):277-84. doi: 10.1007/BF00428937. Psychopharmacologia. 1975. PMID: 168604
-
Antineoplastic activity of cannabinoids.J Natl Cancer Inst. 1975 Sep;55(3):597-602. doi: 10.1093/jnci/55.3.597. J Natl Cancer Inst. 1975. PMID: 1159836
-
Cannabinol and Sleep: Separating Fact from Fiction.Cannabis Cannabinoid Res. 2021 Oct;6(5):366-371. doi: 10.1089/can.2021.0006. Epub 2021 Aug 31. Cannabis Cannabinoid Res. 2021. PMID: 34468204 Free PMC article. Review.
-
Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.Pharmacology. 1974;11(1):3-11. doi: 10.1159/000136462. Pharmacology. 1974. PMID: 4610598 Review. No abstract available.
Cited by
-
Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against Salmonella typhimurium and S. newington.Molecules. 2022 Apr 21;27(9):2669. doi: 10.3390/molecules27092669. Molecules. 2022. PMID: 35566019 Free PMC article.
-
Interaction of cannabidiol and alcohol in humans.Psychopharmacology (Berl). 1979;66(1):45-50. doi: 10.1007/BF00431988. Psychopharmacology (Berl). 1979. PMID: 120541 Clinical Trial.
-
[Cannabinoids--signal transduction and mode of action].Schmerz. 2005 Nov;19(6):528-34. doi: 10.1007/s00482-004-0349-8. Schmerz. 2005. PMID: 15549420 Review. German.
-
Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes.Sci Rep. 2020 Feb 24;10(1):3309. doi: 10.1038/s41598-020-60172-6. Sci Rep. 2020. PMID: 32094454 Free PMC article.
-
Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.Neuroscience. 2012 Mar 1;204:207-29. doi: 10.1016/j.neuroscience.2011.11.020. Epub 2011 Nov 17. Neuroscience. 2012. PMID: 22123166 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources